Eloxx Pharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
ELOX on OTC
Location
480 Arsenal Way, Suite 130, Watertown, MA

There are no Buy or Sell transactions made by insiders since 11/21/2023

Eloxx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pontifax Management 4 G.P. (2015) Ltd. 10%+ Owner $444K May 13, 2021
Sumit Aggarwal PRESIDENT AND CEO, Director $43.2K Oct 16, 2024
Daniel E. Geffken Interim Cfo $36K Nov 29, 2021
Neil S. Belloff Coo, General Counsel &Corp Sec $30.3K Jul 30, 2021
Steven D. Rubin Director $5.4K Oct 16, 2024
Alan Edmund Walts Director $5.4K Oct 16, 2024
Lindsay Androski Director $5.4K Oct 16, 2024
Rajesh B. Parekh Director Jun 15, 2022
Gadi Veinrib Director Jun 15, 2022
Ran Nussbaum Director Jun 15, 2022
Jasbir Seehra Director Jun 15, 2022
Zafrira Avnur Director Jun 15, 2022
Vijay Modur Head Of R&D Jan 25, 2023
Tomer Kariv Director Jan 30, 2023

Recent Insider Transactions by Companies or Individuals for Eloxx Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.